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IRIS  4 
The Iowa Department of Public Health 
(IDPH) has launched an information 
campaign intended to encourage Iowans 
to get their seasonal 
influenza vaccination. 
“The Flu Ends With 
U” campaign includes 
radio, television and 
print messaging; and 
Internet-based 
elements. 
 
“We want everyone to 
know that the most 
effective way to stop 
the spread of the flu 
is to get the flu 
vaccine each year,” 
said IDPH 
Immunization Bureau Chief Don 
Callaghan. “IDPH and the Centers for 
Disease Control and Prevention 
recommend influenza vaccination for 
everyone 6 months of age and older.”    
 
This year’s vaccine will protect against 
the three main influenza viruses that 
research indicates will cause the most 
illness. This season’s flu vaccine will 
protect against 2009 H1N1, an A-H3N2, 
and a B-Brisbane virus. 
 
Healthy people, including healthy 
children and young adults, can get 
very ill from the flu and can spread 
the flu to others. By getting a yearly 
flu vaccine you can protect yourself 
from illness, and protect those 
around you. It is especially 
important to be vaccinated if you 
have vulnerable people in your 
household such as babies, children 
with asthma, and the elderly.  
 
Influenza is a respiratory illness 
that most often causes fever, 
headache, extreme tiredness, 
muscle pain, nonproductive 
coughing, sore throat and a runny nose. 
Occasionally, diarrhea can accompany 
the respiratory symptoms in children.  
 
The flu virus is spread when people who 
are ill cough or sneeze without covering 
their mouths and noses, sending tiny 
droplets of respiratory secretions into the 
air for others to breathe in and get sick.  
Continued on page 2 
 
unization Program
Influenza Dose Clarification 
All children ages 6 months through 8 years who receive a seasonal influenza vaccine 
for the first time should be given 2 doses.  
 Children who receive only 1 dose of a seasonal influenza vaccine in the first 
influenza season they receive vaccine should receive 2 doses, rather than 1, in the 
following influenza season.  
 For the 2010-11 influenza season, children ages 6 months through 8 years who did 
not receive at least 1 dose of an influenza H1N1 2009 monovalent vaccine should 
receive 2 doses of a 2010-11 seasonal influenza vaccine, regardless of previous 
seasonal influenza vaccination history.  
 Children ages 6 months through 8 years for whom the 2009-10 seasonal vaccine 
or influenza A (H1N1) monovalent vaccine history cannot be determined should 
receive 2 doses of a 2010-2011 seasonal influenza vaccine.  
1 
A person can also get the flu by touching a surface or object (such as a door handle) that has been touched by 
someone with the flu (who coughed into their hand) and then touching their own mouth, eyes or nose.  
 
The flu vaccine is plentiful this year, and is available in both injectable and mist presentation. For more information 
about ‘The Flu Ends With U’ campaign, visit www.TheFluEndsWithUIowa.com. 
 
For questions regarding the flu vaccine call Terri Thornton or Bethany Kintigh at 1-800-831-6293 ext. 2 & 7, 
respectively. For questions regarding VFC flu vaccine availability contact Tina Patterson at 1-800-831-6293 ext. 4.  
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The Flu End With U, Continued 
Beginning January 1, 2011, the 
Immunization Program will no 
longer print Vaccine Information 
Statements (VIS) for distribution 
by the Health Protection 
Clearinghouse.  This change will 
allow the most current version of 
the VISs to be available for health 
care providers and patients as 
required by the National 
Childhood Vaccine Injury Act.  
Information regarding the 
requirement to provide VISs is 
available by clicking here. 
In addition, printing 
large quantities of 
VISs often times 
results in waste 
when changes are 
made.  Reducing 
waste will allow 
the Immunization 
Program to 
maximize funds for 
other 
immunization 
projects and 
activities. The 
most current 
version of VISs 
are available to 
download from the 
Centers for 
Disease Control and Prevention’s 
(CDC) website or the 
Immunization Action Coalition’s 
website. 
Health care providers can use the 
above links to subscribe to an 
email notice when VISs are updated.  
Downloading the VISs from the 
internet will ensure the most current 
VIS is provided to patients.  
To further reduce the need for 
printed VISs, health care providers 
can provide a VIS for the parent/
guardian to take home via email or 
mobile device.  The law requires a 
VIS must be provided prior to the 
administration of the vaccine but 
does allow the parent/guardian to 
choose to download the VIS to a 
mobile device rather than take away 
the paper copies.  
Additional information 
regarding this is 
available by 
clicking here. 
The Health 
Protection 
Clearinghouse will 
continue to 
distribute existing 
supplies of the 
VISs until 
inventory is 
depleted or 
outdated.  As 
inventory is 
depleted the 
online Literature Order Form will be 
updated to reflect items that are still 
available to order.  Orders may be 
placed on the Immunization Program 
website or by calling 1-888-398-
9696.   
 
VIS Changes 
National Influenza Vaccination Week 
(NIVW) is a national observance that 
was established to highlight the 
importance of 
continuing influenza 
vaccination, as well as 
fostering greater use 
of flu vaccine after the 
holiday season into 
January and beyond. The 2010-2011 
season’s NIVW is scheduled for 
December 5 thru 11, 2010. For 
more information click here. 
National Influenza 
Vaccination Week 
The Immunization Program will 
continue to print and supply  
immunization materials such as 
brochures and educational  
materials that have historically 
been available from the 
Clearinghouse.   
Anthrax  3/10/10        
MMRV  5/21/10 
Chickenpox     3/13/08    
Multi-vaccine 9/18/08  
DTaP/DT/DTP 5/17/07   
PCV   4/16/10 
Hepatitis A   3/21/06     
PPSV  10/06/09 
Hepatitis B   7/18/07     
Polio  1/01/00 
Hib   12/16/98    
Rabies  10/06/09  
HPV   3/30/10     
Rotavirus  5/14/10  
Influenza (LAIV) 8/10/10   
Shingles   10/06/09  
Influenza (TIV) 8/10/10    
Smallpox  11/15/03 
Japan. enceph. 3/01/10   
Td/Tdap   11/18/08 
Meningococcal 1/28/08   
Typhoid    5/19/04 
MMR  3/13/08      
Current VISs and dates 
3 
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 Question Corner 
immunosuppressive therapy 
(including long-term systemic 
corticosteroids); and those who 
have received an organ or bone 
marrow transplant.  
 
Some physicians in our area 
order PPSV (pneumococcal 
polysaccharide vaccine) every 5 
or 6 years for their patients. Is 
this correct? 
CDC recommends 1 dose of PPSV 
for most people in a lifetime and 2 
doses for certain people. PPSV is a 
polysaccharide vaccine that does 
not boost well, and data do not 
indicate that more than 2 doses are 
beneficial.  
 
I'm confused about the various 
vaccines that contain tetanus, 
diphtheria, and pertussis. Can 
you explain?   
 Two basic products can be used in 
children younger than age 7 years 
(DTaP and DT) and two that can be 
used in older children and adults (Td 
and Tdap). Some people get 
confused between DTaP and Tdap 
and others get confused between 
DT and Td. Continued on page 5 
 
soon as vaccine becomes available. 
Early vaccination of children younger 
than age 9 years who are first time 
vaccinees (or who failed to get their 
second dose in the preceding season) 
can be helpful in assuring routine 
second doses before the influenza 
season begins. 
 
Who needs to be vaccinated with 
PPSV (pneumococcal 
polysaccharide vaccine)? 
1. Vaccinate all previously 
unvaccinated adults age 65 years 
and older. 
2. Vaccinate all adults who smoke 
cigarettes. 
3. Vaccinate persons ages 2–64 
years who 
 have chronic cardiovascular 
disease (e.g., congestive heart 
failure, cardiomyopathy), 
chronic pulmonary disease 
(e.g., COPD, emphysema, 
adults with asthma), or diabetes 
mellitus, or who are cochlear 
implant patients. 
 have chronic liver disease 
(including cirrhosis), are 
alcoholic, or have a 
cerebrospinal fluid leak. 
 live in special environments or 
social settings (e.g., adults ages 
50–64 years who are Alaska 
Natives or certain American 
Indian populations if 
recommended by local health 
authorities). 
4. Vaccinate persons ages 2–64           
years with functional or anatomic 
asplenia (including persons with 
sickle cell disease or 
spleenectomy patients). 
5. Vaccinate 
immunocompromised persons 
age 2 years and older, 
including those with HIV 
infection, leukemia, 
lymphoma, Hodgkin’s 
disease, multiple myeloma, 
generalized malignancy, 
chronic renal failure (including 
dialysis patients), or nephrotic 
syndrome; those receiving 
 
Who is recommended to get 
vaccinated against influenza? 
Beginning with the 2010-11 
vaccination season, ACIP 
recommends annual vaccination 
for all people ages 6 months and 
older who do not have a 
contraindication to the vaccine. 
 
We're glad that CDC has made 
a universal influenza 
vaccination  
recommendation to vaccinate 
everyone 6 months and older. 
Would you tell us how this 
came about? 
Prior to the 2010-11 vaccination 
season, only children ages 6 
months through 18 years and 
adults age 50 years and older 
were universally recommended 
for vaccination; recommendations 
for adults ages 19 through 49 
years were targeted to people 
with specific risk factors, although 
other adults could be vaccinated if 
they wanted protection. 
Collectively, these targeted risk 
groups made up 85 percent of the 
U.S. population. During the 2009 
H1N1 outbreak, additional risk 
groups were identified, such as 
obese individuals. The 
recommendation made by ACIP 
in February 2010 for universal 
vaccination simplifies previous 
recommendations, making it 
easier for health care providers to 
determine whom to vaccinate. 
The universal recommendation 
also makes it easier for patients to 
remember to get vaccinated every 
year. 
 
When should influenza vaccine 
be given? 
You can begin offering vaccine as 
 Save the Date!! 
Mark your calendars now for 
the Statewide 2011 
Immunization Conference 
to be held in Des Moines at the 
Iowa Event 
Center Hy-
Vee Hall on 
June 8 and 9.  
More details 
and 
registration 
information 
to come. 
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A shortage of Hib vaccine began in late 2007 
when Merck voluntarily recalled certain lots of  
PedvaxHIB (Hib) and Comvax (Hib-HepB) 
vaccines and temporarily suspended 
production.  
 
Health care providers were advised to 
conserve the limited supply of the other Hib-
containing products (e.g., Sanofi's ActHIB 
[Hib] and Pentacel [DTaP-Hib/IPV] vaccines) 
by temporarily deferring the routine Hib 
booster dose in healthy children. This 
recommendation was in effect until mid-2009.  
 
In July 2009, Sanofi increased production of 
its two Hib-containing vaccines. In August 
FDA licensed GSK's Hiberix for use as the 
booster (final) dose of the vaccine series for 
children ages 15 through 59 months. Thus, 
health care providers were instructed to recall 
all children who were in need of the booster 
dose and who had not yet reached their fifth 
birthday.  
 
All children less than 5 years old need at 
least one dose of Hib vaccine on or after 
the first birthday. The last dose should be 
separated from the previous dose by at 
least 2 months. 
A Reminder About HIB Boosters 
Vaccine 
Age at 1st 
Dose 
(months) 
Primary Series Booster 
ActHib or Pentacel 
(Sanofi) 
2-6 3 doses, 2 months apart 12-15 months1 
7-11 2 doses, 2 months apart 12-15 months1 
12-14 1 dose 2 months later 
15-59 1 dose --- 
        
PedvaxHib or 
Comvax 
(Merck) 
2-6 2 doses, 2 months apart 12-15 months1 
7-11 2 doses, 2 months apart 12-15 months1 
12-14 1 dose 2 months later 
15-59 1 dose --- 
      
Hiberix 
(GlaxoSmithKline) Not licensed for Primary Series 
15 months2 of 
age through 
4 years of age. 
1 At least 2 months after previous dose. 
 
2 To facilitate timely booster vaccination, Hiberix and other Hib conjugate vac-
cines can be administered as early as age 12 months, in accordance with Hib 
vaccination schedules for routine and catch-up immunization. 
 
The number of doses in the primary series depends on the type of vaccine used.  
A booster dose is recommended at 12-15 months of age regardless of which 
vaccine is used for the primary series.  Any brand can be used for the booster 
dose.  
On September 9, 2010, the Iowa 
Department of Public Health held a 
webinar to announce the transition 
from the existing Immunization 
Registry Information System (IRIS) 
to a version of the Wisconsin 
Immunization Registry (WIR).  The 
change is necessary to meet 
registry functional standards to 
exchange immunization information 
with Electronic Health Record 
(EHR) systems and Iowa’s Health 
Information Exchange (HIE).  
 
To make the decision to utilize the 
WIR system, the Department 
conducted research of software 
applications and other states’ 
Immunization Information Systems 
(IIS) to determine options to timely 
meet the required functional 
standards.  Options included 
obtaining programs to enhance IRIS 
or utilizing existing registries used by 
other states.     
 
The WIR application is used by 16 
states, including three of Iowa’s 
bordering states (NE, MN and WI).  
Enhancements from each state are 
made available to all states using a 
version of WIR, which provides 
enhanced registry functionality, 
reduces programming costs, ensures 
greater interoperability across states, 
and allows participating states to 
maintain compliance with federal 
registry standards.   
 
Transitioning to the WIR 
application will allow IDPH to: 
 Achieve CDC functional 
standards  
 Electronically exchange 
immunization records with 
EHRs and the state HIE,  
 Reduce duplicate 
immunization records through 
enhanced automated de-
duplication tools,  
 Export immunization data to 
allow users to conduct 
immunization assessments, 
and 
Continued on page 6 
 
IRIS Update 
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Here's a hint to help you remember. The 
pediatric formulations usually have 3-5 
times as much of the diphtheria component 
than what is in the adult formulation. This is indicated by an 
uppercase "D" for the pediatric formulation (i.e., DTaP, DT) 
and a lowercase "d" for the adult formulation (Tdap, Td). The 
amount of tetanus toxoid in each of the products is 
equivalent, so it remains an uppercase "T."  
 
Someone gave Tdap to an infant instead of DTaP. Now 
what should be done?  
If Tdap was inadvertently administered to a child, it should 
not be counted as either the first, second, or third dose of 
DTaP. The dose should be repeated with DTaP. Continue 
vaccinating on schedule. If the dose of Tdap was 
administered for the fourth or fifth DTaP dose, the Tdap dose 
can be counted as valid. Clip out the chart below for a quick 
reference in case of inadvertent administration.  
 
How soon after a dose of Td can someone receive a dose 
of Tdap? 
If they have not previously received Tdap, the person should 
receive a single dose of Tdap as soon as feasible and without 
regard to the dosing interval since the last Td. There is no 
"minimum interval" one needs to wait between receiving Td 
and Tdap when it is given to protect infants or other 
vulnerable patients.  
Tdap/DTaP Inadvertent Administration Flow Chart 
Child Less Than 7 Years of Age 
Doses 1-2-3 
Scenario: Tdap given inadvertently 
 
Action: Repeat As Soon As Possible with  DTaP 
 Doses 4-5 
Scenario:  Tdap given inadvertently 
Action: Count as a valid dose.   
Do not need to repeat using DTaP. 
Notes: Routine Tdap vaccination recommendation would  
apply when the child becomes an adolescent.   
 
 
Scenario: Tdap given inadvertently  
Action: Count the Tdap as a valid/protective dose.   
This dose counts as the single adolescent Tdap dose. 
 
Notes:  Future doses should be Td every  5-10 years. 
Child 7-9 Years of Age 
 
 
Scenario: DTaP given inadvertently 
Action:  Count DTaP as a valid/protective dose.   
This dose should be counted as the single Tdap booster.   
 
Notes: Future doses should be Td: every  5-10 years. 
Adult 
Question Corner 
Protect Your Vaccine Supply 
A clinic recently lost a 
considerable amount of influenza 
vaccine because it was taken out 
of the original box.  The vaccine 
was removed from its original 
packaging and was transported to 
an off-site influenza clinic. The 
transport cooler was not large 
enough to hold the vaccine in its 
original  packaging.  Upon return 
to the clinic the vaccine was 
placed in a tray in the refrigerator.  
The storage unit was a purpose 
built, with a glass front door and interior light on at 
all times.  After reading the package insert 
statement about protecting the vaccine from light, 
the clinic called the vaccine manufacturer.   The 
vaccine manufacturer was unable to provide 
efficacy data due to the timeframe the vaccine was 
exposed to light. 
 
HPV, MMR, MMRV, rotavirus, varicella, zoster, 
meningitis, and several influenza vaccines are 
sensitive to light, which causes loss of potency.  
These vaccines must be protected from light at all 
times.  It is important to store these vaccines at the 
appropriate temperatures in their boxes with the 
tops on until they are needed.  For questions 
regarding storage and handling call Terri Thornton 
at 1-800-831-6292 ext. 2.  
Reasons to keep 
vaccines in their 
original boxes/
packaging:  
protection from 
light, preserve the 
temperature 
buffer, and aides 
in vaccine 
recognition. 
5 
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Severe Weather Events 
Is Your Vaccine Supply 
Winter snow and ice storms can have devastating effects on resources such 
as power and transportation, which in turn may affect proper vaccine 
storage. Nationwide, the Vaccines for Children (VFC) Program maintains 
inventories in the field valued at over $11 billion. Safeguards to protect this 
vaccine against inclement weather are vital.   
 
To protect the national vaccine inventory, health care providers should 
develop a written emergency plan. Review and update your plan on an 
annual basis.  It is also important to review and exercise the plan yearly with 
all staff. 
 
Emergency procedures should address vaccine protection and/or retrieval.  
When there is reasonable cause to believe emerging conditions will disrupt 
vaccine operations, emergency procedures should be implemented in 
advance of the event.    
 
Before the emergency, providers should identify an alternative storage 
facility (e.g., a hospital with a backup generator) where the vaccine can be 
properly stored and monitored; ensure availability of staff to pack and move 
the vaccine; access to appropriate packing materials (insulated containers, 
ice packs, dry ice for Varicella vaccine); and insure a means of transport for 
the vaccine to the secure storage facility. Whenever possible, facilities 
should suspend vaccination activities BEFORE the onset of emergency 
conditions to allow sufficient time for packing and transporting vaccine.  
 
The Immunization Program has developed a Vaccine Storage and Handling 
Guidelines template, Emergency Response Plan, & Worksheet to assist 
your facility with the planning process.  These documents are available on 
the Immunization Program website.  
 
Questions? Contact Terri Thornton at 1-800-831-6293 ext. 2. 
During the holiday season 
McKesson 
will NOT ship vaccine from    
  November 24-26  and  December 22- January 3.   
 
In addition, vaccine orders will NOT be distributed during periods of extreme cold and snow.  It is crucial that 
vaccine wastage is minimized and vaccine remains efficacious and viable.  Pay close attention to 
your vaccine inventory throughout the winter. For questions regarding vaccine shipping, call 
Janean Iddings at 1-800-831-6293 ext. 5.  
VFC Vaccine Shipments 
Upon delivery of the shipment, VFC Program providers should verify that the inventory received 
matches the shipping invoice included in the shipping container. 
 
 IRIS users should also verify the vaccine lot number information in IRIS matches the information 
on the order receiving tab. If a discrepancy is identified contact the IRIS Help Desk at 800-374-3958.  It is 
important to contact the IRIS Help Desk staff to correct this issue prior to receiving the order through IRIS. 
IRIS Update 
continued 
 
 Expand provider reporting, 
thereby allowing access to 
additional provider 
immunization data and in 
multiple file formats.   
 
The WIR application will be 
provided free of charge to the 
Department.  The IDPH will work 
with a vendor to make 
enhancements to the WIR 
application, maintain the 
application, convert existing 
registry data to the new 
application, and provide user 
training.   
 
Updates will be provided as 
additional information is available.  
The Immunization Program will 
provide updates via the IRIS list 
serve.  To join, send a blank email 
message to join-
IRISUSERS@lists.ia.gov.   
 
If you have questions contact Kim 
Tichy, IRIS Coordinator at 
ktichy@idph.state.ia.us or 1-800-
374-3958.   
 
Information from the September 9 
webinar is available on the IRIS 
webpage.   
Pertussis Facts 
1. Pertussis is the only 
vaccine preventable disease 
that is on the rise in the 
U.S. In 2010, pertussis was 
declared an epidemic in several 
states that are experiencing 
high incidence of the disease 
that resulted in the deaths of 
numerous infants. 
2. During a pertussis outbreak, 
children who have received all 
their pertussis vaccinations are 
six times less likely to become 
infected than those who have 
never been vaccinated. 
 
3. Seventy percent of infants 
who contract pertussis are 
infected by their own family 
members. Most unvaccinated 
children living with a family 
member with pertussis 
will contract the disease. 
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The ACIP (Advisory Committee on Immunization Practices) is a federal 
advisory committee that provides recommendations to the Secretary and 
Assistant Secretary for Health and Human Services, and the Director of the 
Centers for Disease Control and Prevention (CDC), regarding use of vaccines 
and the recommended immunization schedule. 
 
The ACIP makes routine recommendations which are posted on their website 
within 3 weeks of an ACIP vote. These changes are provisional until 
published in the  MMWR (CDC’s Morbidity and Mortality Weekly Report) at 
which they become official. Currently, there are several changes proposed by 
the ACIP and are expected to be published in the upcoming issue of the 
MMWR.  
 
Proposed changes to the recommended use of Tdap in adults 65 years 
of age and older 
Adults aged 65 years and older who have or anticipate having  close contact 
with infants aged younger than 1 year (such as grandparents and health care 
providers) should receive a single dose of Tdap to protect against pertussis 
and reduce the likelihood of transmission in infants less than 12 months. 
 
Proposed changes to the recommended use of Tdap in children between 
7 - 10 years of age  
Children aged 7 to 10 years who have never been vaccinated against tetanus, 
diphtheria or pertussis or who have unknown vaccination status should 
receive a series of three vaccinations containing tetanus and diphtheria 
toxoids.  
The preferred schedule is a single dose of Tdap followed by a dose of Td 
more than 4 weeks after Tdap and then followed by another dose of Td 6 to 
12 months later. If not administered as the first dose, Tdap can be substituted 
for any other Td doses in the series. 
 
Proposed changes to the recommended use of meningococcal 
conjugate vaccine 
Continue routine vaccination with the quadrivalent meningococcal conjugate 
vaccine for children aged 11 to 12 years followed by a one-time booster dose 
5 years after administration of the first dose through 21 years of age. 
 
Recommendations for a two-dose primary series with meningococcal 
conjugate vaccine in those with persistent complement component 
deficiencies, such as asplenia and HIV, who have not been previously 
vaccinated should receive a dose at 0 and 2 months followed by a booster 
dose at a recommended interval. 
 
For questions regarding these recommendations call Terri Thornton or 
Bethany Kintigh at 1-800-831-6293 ext. 2 & 7, respectively.   
ACIP Changes & You 
The Bureau of Immunization and TB welcomes Bethany Kintigh RN, BSN as the new Maternal 
Hepatitis B and Immunization Education Coordinator.   
Bethany brings to this position 10 years of public health experience gained while serving as the 
Public Health Coordinator for Adair County Public Health.  Her experience includes coordinating 
public health programs, conducting surveillance and epidemiological investigations, and public 
health preparedness for Adair County. Bethany has a Bachelor of Science in Nursing from the 
College of Saint Mary, Omaha, NE.   
